DBV Technologies SA

06/07/2022 | Press release | Distributed by Public on 06/07/2022 14:24

DBV Technologies Announces Positive Topline Results from Phase 3 EPITOPE Trial of Viaskin Peanut in Peanut- Allergic Toddlers